Thermo Fisher Scientific has entered a strategic data collaboration with HealthVerity, a real-world data (RWD) marketplace, to enhance data-driven clinical development and evidence generation for biopharma sponsors. Through the agreement, Thermo Fisher’s PPD clinical research business will gain enterprise-level access to HealthVerity’s TaXOnomy claims dataset, representing more than 270 million de-identified patient lives across the U.S. healthcare system. The datasets will provide insight...